Clinical applications of epigenetic signatures in chronic pain management and health outcome prediction.
Ben Amar, Jinane, Michiels, Joni, Hendrix, Jolien et al.·Epigenomics·2026
This review examined how epigenetic changes—chemical switches that turn genes on and off without altering DNA itself—are observed in chronic pain conditions including fibromyalgia and ME/CFS. Researchers found that alterations in DNA methylation and other epigenetic marks are associated with inflammation, pain signaling, and sensitization pathways. The review suggests that epigenetic markers may one day help identify people at risk or predict outcomes, though these applications remain preliminary and require further development.